Gene therapy for cardiac diseases: methods, challenges, and future directions

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Gene therapy is rapidly advancing, with recent clinical trial successes boosting scientific confidence.
• The cardiac gene therapy field is now accelerating, addressing challenges in treating genetic heart conditions.
• Monogenic cardiac diseases are prime targets due to clear molecular mechanisms and potential for genetic intervention.

Purpose of the Study:

• To review recent advancements in cardiac gene therapy for inherited cardiac diseases.
• To discuss various molecular strategies and delivery vectors, evaluating their therapeutic potential and limitations.
• To identify key factors influencing the clinical translation of cardiac gene therapy.

Main Methods:

• Literature review of recent advancements in cardiac gene therapy.
• Analysis of different molecular approaches and delivery vectors.
• Examination of clinical trial data and prospects for inherited cardiac diseases.

Main Results:

• Cardiac gene therapy is overcoming biological and technical hurdles.
• Monogenic heart diseases represent a significant 'genetically druggable' area.
• Current treatments for these disorders are limited, highlighting the need for novel therapeutic strategies.

Conclusions:

• Cardiac gene therapy shows significant promise for treating inherited cardiac diseases.
• Careful consideration of molecular approaches, delivery vectors, and clinical translation factors is crucial.
• Ongoing research and development are essential to realize the full therapeutic potential of gene therapy in cardiology.